230 related articles for article (PubMed ID: 24458148)
1. A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model.
Iwamoto K; Birkholz P; Schipper A; Mata D; Linn DM; Linn CL
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1078-87. PubMed ID: 24458148
[TBL] [Abstract][Full Text] [Related]
2. Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.
Mata D; Linn DM; Linn CL
Neuropharmacology; 2015 Dec; 99():337-46. PubMed ID: 26239818
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.
Iwamoto K; Mata D; Linn DM; Linn CL
Neuroscience; 2013 May; 237():184-98. PubMed ID: 23402849
[TBL] [Abstract][Full Text] [Related]
4. Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.
Zhou X; Cheng Y; Zhang R; Li G; Yang B; Zhang S; Wu J
Sci Rep; 2017 May; 7(1):1734. PubMed ID: 28496108
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models.
Webster SE; Sklar NC; Spitsbergen JB; Stanchfield ML; Webster MK; Linn DM; Otteson DC; Linn CL
Exp Eye Res; 2021 Sep; 210():108717. PubMed ID: 34348130
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
7. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss.
Blanco R; Martínez-Navarrete G; Valiente-Soriano FJ; Avilés-Trigueros M; Pérez-Rico C; Serrano-Puebla A; Boya P; Fernández E; Vidal-Sanz M; de la Villa P
Exp Eye Res; 2017 Nov; 164():37-45. PubMed ID: 28827028
[TBL] [Abstract][Full Text] [Related]
8. Evidence of BrdU-positive retinal neurons after application of an Alpha7 nicotinic acetylcholine receptor agonist.
Webster MK; Cooley-Themm CA; Barnett JD; Bach HB; Vainner JM; Webster SE; Linn CL
Neuroscience; 2017 Mar; 346():437-446. PubMed ID: 28147247
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension.
Kim ML; Sung KR; Kwon J; Choi GW; Shin JA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830387
[TBL] [Abstract][Full Text] [Related]
10. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma.
Colafrancesco V; Parisi V; Sposato V; Rossi S; Russo MA; Coassin M; Lambiase A; Aloe L
J Glaucoma; 2011 Feb; 20(2):100-8. PubMed ID: 20436364
[TBL] [Abstract][Full Text] [Related]
11. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.
Tsai JC; Wu L; Worgul B; Forbes M; Cao J
Curr Eye Res; 2005 Nov; 30(11):1025-31. PubMed ID: 16282136
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action.
Swartz MM; Linn DM; Linn CL
Neuropharmacology; 2013 Oct; 73():111-21. PubMed ID: 23727438
[TBL] [Abstract][Full Text] [Related]
15. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration.
Salinas-Navarro M; Alarcón-Martínez L; Valiente-Soriano FJ; Jiménez-López M; Mayor-Torroglosa S; Avilés-Trigueros M; Villegas-Pérez MP; Vidal-Sanz M
Exp Eye Res; 2010 Jan; 90(1):168-83. PubMed ID: 19835874
[TBL] [Abstract][Full Text] [Related]
16. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
Guo L; Salt TE; Maass A; Luong V; Moss SE; Fitzke FW; Cordeiro MF
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):626-33. PubMed ID: 16431960
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
18. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.
Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ
Exp Eye Res; 2011 Apr; 92(4):299-305. PubMed ID: 21272576
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
Liu H; Anders F; Thanos S; Mann C; Liu A; Grus FH; Pfeiffer N; Prokosch-Willing V
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5129-5141. PubMed ID: 28986598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
